Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-021437
Filing Date
2023-02-14
Accepted
2023-02-14 15:45:32
Documents
1
Group Members
FAIRMOUNT HEALTHCARE FUND GP LLCFAIRMOUNT HEALTHCARE FUND II GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm235981d4_sc13ga.htm SC 13G/A 90624
  Complete submission text file 0001104659-23-021437.txt   92254
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Subject) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91849 | Film No.: 23628176
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428 267-262-5300
Fairmount Funds Management LLC (Filed by) CIK: 0001802528 (see all company filings)

EIN.: 364841215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A